Seeking AlphaMon, 27 Apr 2026 21:51:37 GMTCompass Therapeutics, Inc. (CMPX) Discusses Positive Secondary Endpoint Results From COMPANION-002 Study in Advanced Biliary Tract Cancer TranscriptCMPX+5.35%
BenzingaMon, 27 Apr 2026 15:44:31 GMTCompass Therapeutics Drops Sharply As Trial Crossover Complicates Survival Data In Bile Duct Cancer PatientsCMPX+5.35%
The Motley FoolMon, 02 Mar 2026 17:29:39 GMTInvestment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC FilingCMPX+5.35%
Zacks Investment ResearchTue, 17 Feb 2026 15:40:50 GMTIs Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?CMPX+5.35%
